Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Effect of HIV infection and antiretroviral therapy on immune cellular functions.

Korencak M, Byrne M, Richter E, Schultz BT, Juszczak P, Ake JA, Ganesan A, Okulicz JF, Robb ML, de Los Reyes B, Winning S, Fandrey J, Burgess TH, Esser S, Michael NL, Agan BK, Streeck H.

JCI Insight. 2019 Jun 20;4(12). pii: 126675. doi: 10.1172/jci.insight.126675. eCollection 2019 Jun 20.

2.

New filovirus disease classification and nomenclature.

Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z.

Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. No abstract available.

PMID:
30926957
3.

Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus Infection.

Valiant WG, Lalani T, Yun HC, Kunz A, Burgess TH, Mattapallil JJ.

Open Forum Infect Dis. 2018 Jun 22;5(7):ofy151. doi: 10.1093/ofid/ofy151. eCollection 2018 Jul.

4.

Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).

Powers JH 3rd, Bacci ED, Leidy NK, Poon JL, Stringer S, Memoli MJ, Han A, Fairchok MP, Coles C, Owens J, Chen WJ, Arnold JC, Danaher PJ, Lalani T, Burgess TH, Millar EV, Ridore M, Hernández A, Rodríguez-Zulueta P, Ortega-Gallegos H, Galindo-Fraga A, Ruiz-Palacios GM, Pett S, Fischer W, Gillor D, Moreno Macias L, DuVal A, Rothman R, Dugas A, Guerrero ML.

PLoS One. 2018 Mar 22;13(3):e0194180. doi: 10.1371/journal.pone.0194180. eCollection 2018.

5.

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.

Powers JH 3rd, Bacci ED, Guerrero ML, Leidy NK, Stringer S, Kim K, Memoli MJ, Han A, Fairchok MP, Chen WJ, Arnold JC, Danaher PJ, Lalani T, Ridoré M, Burgess TH, Millar EV, Hernández A, Rodríguez-Zulueta P, Smolskis MC, Ortega-Gallegos H, Pett S, Fischer W, Gillor D, Macias LM, DuVal A, Rothman R, Dugas A, Ruiz-Palacios GM.

Value Health. 2018 Feb;21(2):210-218. doi: 10.1016/j.jval.2017.04.014. Epub 2017 Jun 7.

6.

Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults.

Bouvier M, Chen WJ, Arnold JC, Fairchok MP, Danaher PJ, Lalani T, Malone L, Mor D, Ridoré M, Burgess TH, Millar EV.

Influenza Other Respir Viruses. 2018 Mar;12(2):299-303. doi: 10.1111/irv.12538. Epub 2018 Feb 2.

7.

Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.

Sun P, Crum-Cianflone NF, Defang G, Williams M, Ganesan A, Agan BK, Lalani T, Whitman T, Brandt C, Burgess TH.

Vaccine. 2017 Oct 27;35(45):6103-6111. doi: 10.1016/j.vaccine.2017.09.059. Epub 2017 Oct 4.

PMID:
28987439
8.

Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report.

Riddle MS, Martin GJ, Murray CK, Burgess TH, Connor P, Mancuso JD, Schnaubelt ER, Ballard TP, Fraser J, Tribble DR.

Mil Med. 2017 Sep;182(S2):34-52. doi: 10.7205/MILMED-D-17-00077.

9.

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.

Beigel JH, Tebas P, Elie-Turenne MC, Bajwa E, Bell TE, Cairns CB, Shoham S, Deville JG, Feucht E, Feinberg J, Luke T, Raviprakash K, Danko J, O'Neil D, Metcalf JA, King K, Burgess TH, Aga E, Lane HC, Hughes MD, Davey RT; IRC002 Study Team.

Lancet Respir Med. 2017 Jun;5(6):500-511. doi: 10.1016/S2213-2600(17)30174-1. Epub 2017 May 15. Erratum in: Lancet Respir Med. 2017 Jul;5(7):e26.

10.

Type-specific clinical characteristics of adenovirus-associated influenza-like illness at five US military medical centers, 2009-2014.

Koren MA, Arnold JC, Fairchok MP, Lalani T, Danaher PJ, Schofield CM, Rajnik M, Hansen EA, Mor D, Chen WJ, Ridoré M, Burgess TH, Millar EV.

Influenza Other Respir Viruses. 2016 Sep;10(5):414-20. doi: 10.1111/irv.12392. Epub 2016 May 13.

11.

Zika virus: A primer for clinicians.

Flores MS, Burgess TH, Rajnik M.

Cleve Clin J Med. 2016 Apr;83(4):261-70. doi: 10.3949/ccjm.83a.16027. Review.

12.

The Epidemiology, Virology and Clinical Findings of Dengue Virus Infections in a Cohort of Indonesian Adults in Western Java.

Kosasih H, Alisjahbana B, Nurhayati, de Mast Q, Rudiman IF, Widjaja S, Antonjaya U, Novriani H, Susanto NH, Jusuf H, van der Ven A, Beckett CG, Blair PJ, Burgess TH, Williams M, Porter KR.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004390. doi: 10.1371/journal.pntd.0004390. eCollection 2016 Feb.

13.

Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.

Deiss RG, Arnold JC, Chen WJ, Echols S, Fairchok MP, Schofield C, Danaher PJ, McDonough E, Ridoré M, Mor D, Burgess TH, Millar EV.

Vaccine. 2015 Dec 16;33(51):7160-7167. doi: 10.1016/j.vaccine.2015.11.004. Epub 2015 Nov 10.

14.

Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance.

Burgess TH, Murray CK, Bavaro MF, Landrum ML, O'Bryan TA, Rosas JG, Cammarata SM, Martin NJ, Ewing D, Raviprakash K, Mor D, Zell ER, Wilkins KJ, Millar EV.

Vaccine. 2015 Jul 31;33(32):3894-9. doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25.

15.

Operation United Assistance: infectious disease threats to deployed military personnel.

Murray CK, Yun HC, Markelz AE, Okulicz JF, Vento TJ, Burgess TH, Cardile AP, Miller RS.

Mil Med. 2015 Jun;180(6):626-51. doi: 10.7205/MILMED-D-14-00691. Review.

PMID:
26032379
16.

Neuraminidase inhibitor therapy in a military population.

Fairchok MP, Chen WJ, Arnold JC, Schofield C, Danaher PJ, McDonough EA, Ottolini M, Mor D, Ridore M, Burgess TH, Millar EV.

J Clin Virol. 2015 Jun;67:17-22. doi: 10.1016/j.jcv.2015.03.018. Epub 2015 Mar 24.

17.

Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children.

Chen WJ, Arnold JC, Fairchok MP, Danaher PJ, McDonough EA, Blair PJ, Garcia J, Halsey ES, Schofield C, Ottolini M, Mor D, Ridoré M, Burgess TH, Millar EV.

J Clin Virol. 2015 Mar;64:74-82. doi: 10.1016/j.jcv.2015.01.007. Epub 2015 Jan 13.

18.

A patient with Fever and rash.

Morgan MK, Whitman TJ, Cohen JI, Pittaluga S, Mitchum MD, Jarell AD, Burgess TH.

Clin Infect Dis. 2014 Jul 1;59(1):95, 136-7. doi: 10.1093/cid/ciu197. No abstract available.

19.

A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donor.

Wallace RM, Stanek D, Griese S, Krulak D, Vora NM, Pacha L, Kan V, Said M, Williams C, Burgess TH, Clausen SS, Austin C, Gabel J, Lehman M, Finelli LN, Selvaggi G, Joyce P, Gordin F, Benator D, Bettano A, Cersovsky S, Blackmore C, Jones SV, Buchanan BD, Fernandez AI, Dinelli D, Agnes K, Clark A, Gill J, Irmler M, Blythe D, Mitchell K, Whitman TJ, Zapor MJ, Zorich S, Witkop C, Jenkins P, Mora P, Droller D, Turner S, Dunn L, Williams P, Richards C, Ewing G, Chapman K, Corbitt C, Girimont T, Franka R, Recuenco S, Blanton JD, Feldman KA.

Zoonoses Public Health. 2014 Dec;61(8):560-70. doi: 10.1111/zph.12105. Epub 2014 Mar 27.

PMID:
24673934
20.

The diagnostic and prognostic value of dengue non-structural 1 antigen detection in a hyper-endemic region in Indonesia.

Kosasih H, Alisjahbana B, Widjaja S, Nurhayati, de Mast Q, Parwati I, Blair PJ, Burgess TH, van der Ven A, Williams M.

PLoS One. 2013 Nov 19;8(11):e80891. doi: 10.1371/journal.pone.0080891. eCollection 2013.

21.

Evidence for endemic chikungunya virus infections in Bandung, Indonesia.

Kosasih H, de Mast Q, Widjaja S, Sudjana P, Antonjaya U, Ma'roef C, Riswari SF, Porter KR, Burgess TH, Alisjahbana B, van der Ven A, Williams M.

PLoS Negl Trop Dis. 2013 Oct 24;7(10):e2483. doi: 10.1371/journal.pntd.0002483. eCollection 2013.

22.

Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.

Defang GN, Martin NJ, Burgess TH, Millar EV, Pecenka LA, Danko JR, Arnold JC, Kochel TJ, Luke TC.

PLoS One. 2012;7(12):e48229. doi: 10.1371/journal.pone.0048229. Epub 2012 Dec 20.

23.

Surveillance of influenza in Indonesia, 2003–2007.

Kosasih H, Roselinda, Nurhayati, Klimov A, Xiyan X, Lindstrom S, Mahoney F, Beckett C, Burgess TH, Blair PJ, Uyeki TM, Sedyaningsih ER.

Influenza Other Respir Viruses. 2013 May;7(3):312-20.

24.

Infectious etiologies of acute febrile illness among patients seeking health care in south-central Cambodia.

Kasper MR, Blair PJ, Touch S, Sokhal B, Yasuda CY, Williams M, Richards AL, Burgess TH, Wierzba TF, Putnam SD.

Am J Trop Med Hyg. 2012 Feb;86(2):246-253. doi: 10.4269/ajtmh.2012.11-0409.

25.

Toward a surrogate marker of malaria exposure: modeling longitudinal antibody measurements under outbreak conditions.

Campo JJ, Whitman TJ, Freilich D, Burgess TH, Martin GJ, Doolan DL.

PLoS One. 2011;6(7):e21826. doi: 10.1371/journal.pone.0021826. Epub 2011 Jul 27.

26.

Health care workers and researchers traveling to developing-world clinical settings: disease transmission risk and mitigation.

Kortepeter MG, Seaworth BJ, Tasker SA, Burgess TH, Coldren RL, Aronson NE.

Clin Infect Dis. 2010 Dec 1;51(11):1298-305. doi: 10.1086/657115. Epub 2010 Nov 1. Review.

PMID:
21039283
27.

An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.

Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ.

Am J Trop Med Hyg. 2010 Aug;83(2):258-65. doi: 10.4269/ajtmh.2010.09-0774.

28.

Hark back: passive immunotherapy for influenza and other serious infections.

Luke TC, Casadevall A, Watowich SJ, Hoffman SL, Beigel JH, Burgess TH.

Crit Care Med. 2010 Apr;38(4 Suppl):e66-73. doi: 10.1097/CCM.0b013e3181d44c1e. Review.

PMID:
20154602
29.

Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness.

Dilantika C, Sedyaningsih ER, Kasper MR, Agtini M, Listiyaningsih E, Uyeki TM, Burgess TH, Blair PJ, Putnam SD.

BMC Infect Dis. 2010 Jan 7;10:3. doi: 10.1186/1471-2334-10-3.

30.

Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability.

Takhampunya R, Palmer DR, McClain S, Barvir DA, Lynch J, Jarman RG, Thomas S, Gibbons RV, Burgess TH, Sun P, Kamau E, Putnak R, Zhang C.

Virus Res. 2009 Oct;145(1):31-8. doi: 10.1016/j.virusres.2009.05.016. Epub 2009 Jun 21.

PMID:
19540887
31.

H5N1 surveillance in migratory birds in Java, Indonesia.

Stoops AC, Barbara KA, Indrawan M, Ibrahim IN, Petrus WB, Wijaya S, Farzeli A, Antonjaya U, Sin LW, Hidayatullah N, Kristanto I, Tampubolon AM, Purnama S, Supriatna A, Burgess TH, Williams M, Putnam SD, Tobias S, Blair PJ.

Vector Borne Zoonotic Dis. 2009 Dec;9(6):695-702. doi: 10.1089/vbz.2008.0183.

PMID:
19271996
32.

Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus.

Sun P, Fernandez S, Marovich MA, Palmer DR, Celluzzi CM, Boonnak K, Liang Z, Subramanian H, Porter KR, Sun W, Burgess TH.

Virology. 2009 Jan 20;383(2):207-15. doi: 10.1016/j.virol.2008.10.022. Epub 2008 Nov 17.

33.

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.

Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, Sun P, Porter K, Rudiman IF, Yuwono D, Puthavathana P, Marovich MA.

J Virol. 2008 Apr;82(8):3939-51. doi: 10.1128/JVI.02484-07. Epub 2008 Feb 13.

34.

Group A rotavirus-associated diarrhea in children seeking treatment in Indonesia.

Putnam SD, Sedyaningsih ER, Listiyaningsih E, Pulungsih SP, Komalarini, Soenarto Y, Salim OCh, Subekti D, Riddle MS, Burgess TH, Blair PJ.

J Clin Virol. 2007 Dec;40(4):289-94. Epub 2007 Oct 30.

PMID:
17977785
35.

The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.

Doolan DL, Freilich DA, Brice GT, Burgess TH, Berzins MP, Bull RL, Graber NL, Dabbs JL, Shatney LL, Blazes DL, Bebris LM, Malone MF, Eisold JF, Mateczun AJ, Martin GJ.

J Infect Dis. 2007 Jan 15;195(2):174-84. Epub 2006 Dec 6.

PMID:
17191162
36.

An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies.

Martin NC, Pardo J, Simmons M, Tjaden JA, Widjaja S, Marovich MA, Sun W, Porter KR, Burgess TH.

J Virol Methods. 2006 Jun;134(1-2):74-85. Epub 2006 Jan 18.

PMID:
16417930
37.

Rapid diagnostic test for Plasmodium falciparum in 32 Marines medically evacuated from Liberia with a febrile illness.

Susi B, Whitman T, Blazes DL, Burgess TH, Martin GJ, Freilich D.

Ann Intern Med. 2005 Mar 15;142(6):476-7. No abstract available.

PMID:
15767635
38.

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.

Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA.

J Exp Med. 2003 Apr 7;197(7):823-9.

39.

Clinicopathologic features of viral agents of potential use by bioterrorists.

Burgess TH, Steele KE, Schoneboom BA, Grieder FB.

Clin Lab Med. 2001 Sep;21(3):475-93, viii. Review.

PMID:
11572138
40.

Quinine Bihydrochloride v. Quinine Bisulphate.

Burgess TH.

Ind Med Gaz. 1909 Sep;44(9):352. No abstract available.

41.

Practical Observations on Diseases of the Skin.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Mar 11;5(128):463-6. No abstract available.

42.

Practical Observations on Diseases of the Skin.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Feb 25;5(126):423-5. No abstract available.

43.

Practical Observations on Diseases of the Skin.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Feb 11;5(124):383-6. No abstract available.

44.

Practical Observations on Diseases of the Skin.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Jan 28;5(122):349-51. No abstract available.

45.

Practical Observations on Diseases of the Skin: No. II. Eruptions of the Face.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Jan 14;5(120):307-10. No abstract available.

46.

Practical Observations on Diseases of the Skin.

Burgess TH.

Prov Med J Retrosp Med Sci. 1843 Jan 7;5(119):285-8. No abstract available.

47.

Cases of Laryngeal Asthma: Or the crowing disease of infants.

Burgess TH.

Prov Med Surg J (1840). 1842 Jan 1;3(66):266-8. No abstract available.

48.

On Nervous Headach from Exhaustion, and Its Treatment with Aconite.

Burgess TH.

Edinb Med Surg J. 1840 Jul 1;54(144):95-105. No abstract available.

Supplemental Content

Loading ...
Support Center